The ECG Devices Market is witnessing sustained growth due to the increasing burden of cardiovascular diseases worldwide. According to market projections, the sector will grow from US$ 3,310.87 million in 2024 to US$ 4,509.53 million by 2031, registering a CAGR of 4.5%. The expansion of healthcare infrastructure and the rising adoption of remote cardiac monitoring solutions are key factors contributing to this growth. 

What's Fueling Market Growth?

The primary engine behind this expansion is the soaring prevalence of cardiovascular diseases (CVDs) worldwide. According to the American Heart Association, CVDs accounted for 19.91 million global deaths in 2021, while the Centers for Disease Control and Prevention reported 702,880 deaths due to heart disease every year and 805,000 people suffering from a heart attack in the US in 2022. These staggering figures are pushing healthcare systems globally to invest in proactive cardiac monitoring. Beyond disease burden, increasing awareness about cardiovascular conditions, development of new technologies, and a surge in government initiatives and healthcare investment are collectively accelerating market adoption. Technological advancements in smart wearables are expected to bring new trends to the ECG devices market in the coming years.

Get Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00039860

Segment Highlights:

The market is segmented across product type, lead configuration, technology, and end user. The resting ECG segment held a larger share of the market in 2023 and is expected to register a higher CAGR during 2024–2031. In terms of lead type, the 12-lead ECG segment held the largest share of the market in 2023, while the single lead ECG segment is expected to register the highest CAGR.

From a technology standpoint, the wireless ECG system segment held a larger share of the market in 2023 and is expected to register a higher CAGR during 2024–2031, reflecting strong demand for remote and real-time cardiac monitoring. Hospitals and clinics dominate the end-user segment and are anticipated to maintain the highest CAGR through 2031.

Regional Landscape

North America held a significant share of the market in 2023, driven by increasing incidence of cardiovascular disease, an increased focus on preventive healthcare, and the presence of well-developed healthcare infrastructure. Meanwhile, Asia Pacific is emerging as a high-growth region. In China alone, 290 million people are suffering from cardiac disorders, including stroke, coronary heart disease, heart failure, and congenital heart disease, creating enormous demand for ECG diagnostics.

Strategic Developments by Key Players

Innovation and collaboration are shaping the competitive landscape. In June 2024, AliveCor received FDA 510(k) approval for the Kardia 12L ECG System, a portable AI-powered ECG device capable of analyzing ECGs to detect up to 35 conditions, including arrhythmias and heart attacks. In a further push for accessibility, OMRON Healthcare India collaborated with AliveCor India in May 2024 to provide AI-based handheld ECG technology, introducing the first home BPM+ECG Monitoring FDA-cleared device for early CVD detection and management.

Additionally, Norav Medical introduced its Chest Strap ECG in January 2025, a sticker-free, allergy-free solution designed for long-term cardiac monitoring, supporting 1–3 channel configurations.

Outlook

The ECG devices market is entering a transformative era where portability, AI integration, and wireless connectivity are redefining cardiac care. With major players like GE Healthcare, Philips, Nihon Kohden, and AliveCor continuously expanding their portfolios, the market is well-positioned for sustained growth through 2031. For healthcare stakeholders, investors, and innovators, the window of opportunity in this space is wide open.

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.

Contact Us:
If you have any queries about this report or if you would like further information, please get in touch with us:
Website: https://www.theinsightpartners.com/
Phone: +1-646-491-9876